Golden logoGolden logo
Advanced Search
InVivo AI

InVivo AI

InVivo AI is a drug development and machine learning company founded in 2018 by Therence Bois, Prudencio Tossou and Daniel Cohen.

InVivo AI is an artificial intelligence enabled drug manufacturing company.

Timeline

April 2019
InVivo AI raises a $1,500,000 seed round from Amplify Capital, Brightspark Ventures, Panache Ventures and Real Ventures.

Funding Rounds

Patents

Further Resources

Title
Author
Link
Type
Date

Valence Discovery Announces Multi-Target AI-Enabled Drug Design Collaboration with Servier -- bioquebec

Web

March 24, 2021

References

Golden logo
By using this site, you agree to our Terms of Service.